These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 13967405)

  • 1. [Antibody responses to vaccination with B. pertussis in mice after fosfotion intoxication].
    BENES V; PEKAREK J; CERNA V
    Cesk Hyg; 1963 Feb; 8():3-6. PubMed ID: 13967405
    [No Abstract]   [Full Text] [Related]  

  • 2. The ability of pertussis vaccine to produce in mice specific immunity of a type not associated with antibody production.
    EVANS DG; PERKINS FT
    Br J Exp Pathol; 1954 Aug; 35(4):322-30. PubMed ID: 13190117
    [No Abstract]   [Full Text] [Related]  

  • 3. [THE CULTURAL AND IMMUNIZING PROPERTIES OF THE PARAPERTUSSIS BACILLUS AND ITS SIGNIFICANCE IN WHOOPING COUGH].
    FINTIKTIKOVA RP; KHARMATS RZ; LOMONOSOVA LA
    Zh Mikrobiol Epidemiol Immunobiol; 1963 Nov; 40():69-73. PubMed ID: 14151764
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum reactome induced by Bordetella pertussis infection and Pertussis vaccines: qualitative differences in serum antibody recognition patterns revealed by peptide microarray analysis.
    Valentini D; Ferrara G; Advani R; Hallander HO; Maeurer MJ
    BMC Immunol; 2015 Jul; 16():40. PubMed ID: 26129684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bordetella pertussis, B. parapertussis, vaccines and cycles of whooping cough.
    Bouchez V; Guiso N
    Pathog Dis; 2015 Oct; 73(7):. PubMed ID: 26242280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-cell responses after intranasal vaccination with the novel attenuated Bordetella pertussis vaccine strain BPZE1 in a randomized phase I clinical trial.
    Jahnmatz M; Amu S; Ljungman M; Wehlin L; Chiodi F; Mielcarek N; Locht C; Thorstensson R
    Vaccine; 2014 Jun; 32(27):3350-6. PubMed ID: 24793938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The altered reactivity of mice after immunization with Hemophilus pertussis vaccine.
    KIND LS
    J Immunol; 1953 Apr; 70(4):411-20. PubMed ID: 13035134
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age.
    Hendrikx LH; de Rond LG; Oztürk K; Veenhoven RH; Sanders EA; Berbers GA; Buisman AM
    Vaccine; 2011 Aug; 29(34):5725-30. PubMed ID: 21669247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bordetella pertussis: why is it still circulating?
    Guiso N
    J Infect; 2014 Jan; 68 Suppl 1():S119-24. PubMed ID: 24103807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on the effects of whooping cough vaccine on the living body, especially experiments by means of electromyography of the respiratory muscles. III. Electromyogram of the intercostal muscles with administration of autonomic drugs after inoculation with whooping cough vaccine, and with inoculation with Bordetella pertussis Type I after reticuloendothelial system depression].
    KURODA I
    Paediatr Jpn; 1961 Jul; 65():681-7. PubMed ID: 13755303
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the soluble fraction of Bordetella pertussis isolated with sodium desoxycholate].
    Soare I; Barber C; Dumitresco M
    Arch Roum Pathol Exp Microbiol; 1964 Dec; 23(4):839-44. PubMed ID: 4284319
    [No Abstract]   [Full Text] [Related]  

  • 12. Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance.
    Dorji D; Mooi F; Yantorno O; Deora R; Graham RM; Mukkur TK
    Med Microbiol Immunol; 2018 Feb; 207(1):3-26. PubMed ID: 29164393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody responses in adult and neonatal BALB/c mice to immunization with novel Bordetella pertussis vaccine formulations.
    Gracia A; Polewicz M; Halperin SA; Hancock RE; Potter AA; Babiuk LA; Gerdts V
    Vaccine; 2011 Feb; 29(8):1595-604. PubMed ID: 21215343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough.
    Winsnes R; Lønnes T; Møgster B; Berdal BP
    Dev Biol Stand; 1985; 61():353-65. PubMed ID: 2872124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and evaluation of Bordetella pertussis live attenuated vaccine strain BPZE1 producing Fim3.
    Debrie AS; Coutte L; Raze D; Mooi F; Alexander F; Gorringe A; Mielcarek N; Locht C
    Vaccine; 2018 Mar; 36(11):1345-1352. PubMed ID: 29433898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [EFFECT OF TOXOIDS ON THE IMMUNOGENIC VALUE OF THE PERTUSSIS COMPONENT].
    TUROWSKI G
    Med Dosw Mikrobiol; 1963; 15():331-5. PubMed ID: 14118921
    [No Abstract]   [Full Text] [Related]  

  • 17. Investigating pertussis toxin and its impact on vaccination.
    Coutte L; Locht C
    Future Microbiol; 2015; 10(2):241-54. PubMed ID: 25689536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathogenetic significance of Bordetella pertussis toxin].
    Finger H
    Immun Infekt; 1985 Apr; 13(2):47-9. PubMed ID: 2860059
    [No Abstract]   [Full Text] [Related]  

  • 19. Pertussis vaccination and whooping cough: and now what?
    Guiso N
    Expert Rev Vaccines; 2014 Oct; 13(10):1163-5. PubMed ID: 25020131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The IgM and IgG response to Bordetella pertussis vaccination and infection.
    Macaulay ME
    J Med Microbiol; 1981 Feb; 14(1):1-7. PubMed ID: 6257906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.